SGLT2 Inhibitors Cut AFib Risk in Real-Word Analysis Uncategorized / June 14, 2022 Observational data add to a growing link between SGLT2 inhibitor treatment and atrial fibrillation prevention in people with type 2 diabetes. Medscape Medical News